Sg3 Management, LLC Enanta Pharmaceuticals Inc Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$60.19 - $97.37 $698,204 - $1.13 Million
-11,600 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$41.02 - $58.65 $139,468 - $199,410
-3,400 Reduced 22.67%
11,600 $659,000
Q1 2021

May 17, 2021
BUY
$41.69 - $54.95 $625,350 - $824,250
15,000 New
15,000 $740,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $177M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email